HS code: 30
To | |
Direction | |
From | |
Period | |
Selection products |
Period | Total |
---|---|
2015 | $800 K |
2016 | $305 K |
Total: | $1.1 M |
Period | Weight, tons. |
---|---|
2015 | 5.47 |
2016 | 2.46 |
Total: | 7.93 |
Group product | 2015 | 2016 | Ch. | ∑ (2015-2016) | Ratio |
---|---|---|---|---|---|
06 3001: Glands and other organs for organo-therapeutic uses | --- | --- | --- | --- | 0% |
06 3002: Human blood; animal blood; vaccines, toxins, cultures of micro-organisms and similar products | $603 K | $274 K | 54% | $877 K | 79.3% |
06 3003: Medicaments consisting of two or more constituents, for retail sale | --- | --- | --- | --- | 0% |
06 3004: Medicaments consisting of mixed or unmixed products for retail sale | $198 K | --- | 100% | $198 K | 17.9% |
06 3005: Wadding, gauze, bandages and similar articles | --- | --- | --- | --- | 0% |
06 3006: Pharmaceutical goods specified in note 4 to this chapter | --- | $30.7 K | --- | $30.7 K | 2.8% |
Total: | $800 K | $305 K | $1.1 M |
№ | Country | ∑ (2015-2016) | Ratio |
---|---|---|---|
1 | Germany | $53.8 M | 18.4% |
2 | Bosnia and Herzegovina | $44.6 M | 15.3% |
3 | Italy | $36.7 M | 12.6% |
4 | Bulgaria | $29.4 M | 10% |
5 | Spain | $23.4 M | 8% |
6 | Switzerland | $20.2 M | 6.9% |
7 | United States | $20.2 M | 6.9% |
8 | Finland | $19.2 M | 6.6% |
9 | Japan | $9.5 M | 3.3% |
10 | Belarus | $6.2 M | 2.1% |
11 | United Kingdom | $5.1 M | 1.8% |
12 | France | $4.6 M | 1.6% |
13 | Denmark | $3.9 M | 1.3% |
14 | China | $3 M | 1% |
15 | South Korea | $2.4 M | 0.8% |
16 | Ukraine | $1.2 M | 0.4% |
17 | Israel | $1.1 M | 0.4% |
18 | Estonia | $1.1 M | 0.4% |
19 | Sweden | $876 K | 0.3% |
20 | Hungary | $806 K | 0.3% |
... | ... | ... | ... |
The total for all countries: | $292 M | 100% |
№ | Region | ∑ (2015-2016) | Ratio |
---|---|---|---|
1 | Moskva | $112 M | 96.6% |
2 | Smolenskaya oblast | $1.9 M | 1.6% |
3 | Sankt-Peterburg | $1.1 M | 1% |
4 | Moskovskaya oblast | $472 K | 0.4% |
5 | Rostovskaya oblast | $471 K | 0.4% |
6 | Belgorodskaya oblast | $18.4 K | 0% |
By all regions: | $116 M | 100% |